reference/17367918

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17367918

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	3
issn	1000-503X
issueIdentifier	2
pageRange	211-3
publicationName	Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
startingPage	211
bibliographicCitation	Li YX, Ding GX, Li QF, Chen L, Hu GL, Ji QH, Wang SJ, Guo Y, Luo R, Hou WK, Wang PN, Zhang NY, Zhang YP, Wang H. [Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Apr;30(2):211–3. PMID: 18505128.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b36fdec99e870af8ab15d3c679ce7647 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_230aceee153543c0cd1fd83b893778aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78e96d0c5123390b1470af82ce6bc294 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5e4c8d6207cd2dd0d5de6be3d8573a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16c4a38a2a55ef9f827ee30d2b2bd2fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7b13d29bfe9152c4aa06606ebfaf486 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4f446b46e858851949aa59426ac8f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4df766d5e0fc161b89efaa80d087d80c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_780c4e9ed8c8cefbb1dbef68330ce26c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f296ee0ad019c3ffa0b8cc535325950c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4be320aed0fb81df63d5d2c98076baf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c353559f50534b11a1c72502445c9efd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89b3e26105f715dc95ae7c197092c99e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62d66d5b99fdf118f37a2845cdc65b56
date	200804
identifier	https://pubmed.ncbi.nlm.nih.gov/18505128
isPartOf	https://portal.issn.org/resource/ISSN/1000-503X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2907
language	Chinese
source	https://pubmed.ncbi.nlm.nih.gov/
title	[Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes]
discusses	http://id.nlm.nih.gov/mesh/M0005469 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0353981 http://id.nlm.nih.gov/mesh/M0016544
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D003510Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001786Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007004Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D010649Q000009 http://id.nlm.nih.gov/mesh/D000077715 http://id.nlm.nih.gov/mesh/D003510Q000009 http://id.nlm.nih.gov/mesh/D003510Q000008 http://id.nlm.nih.gov/mesh/D010649Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010649Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7062 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65981 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_53faa2858321bc9be34429d975b50e0a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129735276 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127816805

Total number of triples: 66.